Ozempic Might Be Much less Efficient for Emotional Eaters, Examine Suggests

GLP-1 agonists—so-called “wonder medicine” like Ozempic or Wegovy that assist people decrease blood sugar ranges and drop pounds, amongst different issues—yield vital outcomes for some sufferers, however not all. Individuals’s motivations to overeat might play a job on this, in response to a brand new examine.

To research why some folks don’t profit from GLP-1 agonists as a lot as others, researchers noticed 92 contributors with sort 2 diabetes in Japan throughout their first 12 months of taking GLP-1 medicine. Their results, revealed as we speak in Frontiers in Scientific Diabetes and Healthcare, counsel that individuals who overeat as a consequence of exterior causes—such because the sight or odor of scrumptious meals—had larger probabilities of responding nicely to the medicine in the long run than individuals who overeat for emotional causes.

Who will profit most from GLP-1 medicine?

“Pre-treatment evaluation of consuming habits patterns might assist predict who will profit most from GLP-1 receptor agonist remedy,” Daisuke Yabe, senior writer of the examine and a professor of diabetes, endocrinology, and vitamin at Kyoto College, stated in a Frontiers assertion. “GLP-1 receptor agonists are efficient for people who expertise weight acquire or elevated blood glucose ranges as a consequence of overeating triggered by exterior stimuli. Nonetheless, their effectiveness is much less anticipated in circumstances the place emotional consuming is the first trigger.”

The group revealed this by gathering information on the contributors’ physique weight and composition, food regimen, and data equivalent to blood glucose, levels of cholesterol, and relationship with meals originally of the remedy, three months after, and one 12 months after. They targeted on emotional consuming (consuming in response to damaging feelings), exterior consuming (consuming as a result of the meals seems good), and restrained consuming (controlling one’s food regimen to drop pounds). Whereas it may appear contradictory, extreme restrained consuming can truly end in disordered consuming, in response to the researchers.

Over the 12 months, the contributors skilled a statistically vital lack of physique weight and lowered levels of cholesterol and physique fats share with out altering skeletal muscle mass. Whereas blood glucose ranges ameliorated, the development wasn’t statistically vital. There have been, nonetheless, some variations relying on consuming behaviors. Three months after the beginning of the remedy, contributors reported extra restrained consuming and fewer exterior or emotional consuming. By the top of the 12 months, although, contributors had returned to their unique restrained and emotional consuming habits.

“One potential clarification is that emotional consuming is extra strongly influenced by psychological components which will not be immediately addressed by GLP-1 receptor agonist remedy,” stated Takehiro Kato, second writer of the article and a researcher from Gifu College, “People with distinguished emotional consuming tendencies might require extra behavioral or psychological assist.”

Exterior consuming lessened over the 12 months of remedy

Contributors reported decreased exterior consuming all through the whole 12 months, and people that claimed excessive ranges of exterior consuming originally of the remedy noticed the best advantages in blood glucose ranges and weight reduction. Alternatively, the group didn’t determine any affiliation between emotional or restrained consuming scores originally and drug advantages by the 12-month mark.

“Whereas our examine suggests a possible affiliation between exterior consuming habits and remedy response to GLP-1 receptor agonists, these findings stay preliminary,” defined Yabe. What’s extra, the group’s examine was observational, and contributors self-reported info, which means the researchers revealed a possible affiliation, not a causation.

“Additional proof is critical earlier than they are often applied in scientific observe. Ought to future large-scale or randomized managed trials validate this relationship, incorporating easy behavioral assessments might grow to be a priceless part in optimizing remedy methods,” Yabe concluded.